Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-07-07T21:11:32.309Z Has data issue: false hasContentIssue false

Chapter 22 - Rating scales and clinical outcome measures in the evaluation of patients with Parkinson's disease

from Section IV - Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges

Published online by Cambridge University Press:  05 March 2016

By
Pablo Martinez-Martin  and
Carmen Rodríguez-Blázquez
Edited by
Néstor Gálvez-Jiménez ,
Hubert H. Fernandez ,
Alberto J. Espay  and
Susan H. Fox
Néstor Gálvez-Jiménez
Affiliation:
Cleveland Clinic, Florida
Hubert H. Fernandez
Affiliation:
Cleveland Clinic, Ohio
Alberto J. Espay
Affiliation:
University of Cincinnati
Susan H. Fox
Affiliation:
Toronto Western Hospital
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Parkinson's Disease
Current and Future Therapeutics and Clinical Trials
 , pp. 231 - 241
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Acquadro, C, Berzon, R, Dubois, D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003; 6: 522–31.Google Scholar
Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193–205.Google Scholar
Mokkink, LB, Terwee, CB, Patrick, DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539–49.Google Scholar
Terwee, CB, Dekker, FW, Wiersinga, WM, Prummel, MF, Bossuyt, PMM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003; 12: 349–62.Google Scholar
Wyrwich, KW, Metz, SM, Kroenke, K, et al. Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. Health Serv Res 2007; 42: 2257–74.Google Scholar
Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–42.Google Scholar
Goetz, CG, Poewe, W, Rascol, O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004; 19: 1020–8.CrossRefGoogle ScholarPubMed
Martínez-Martín, P, Forjaz, MJ, Cubo, E, Frades, B, de Pedro Cuesta, J. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 2006; 21: 208–14.Google Scholar
Martínez-Martín, P, Rodríguez-Blázquez, C, Forjaz, MJ, de Pedro, J. The Clinical Impression of Severity Index for Parkinson's Disease: international validation study. Mov Disord 2009; 24: 211–17.Google Scholar
Fahn, S, Elton, R, UPDRS Program Members. Unified Parkinson's Disease Rating Scale. In: Fahn, S, Marsden, C, Goldstein, M, Calne, D, eds. Recent Developments in Parkinson’s Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987; 153–63.Google Scholar
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003; 18: 738–50.Google Scholar
Steffen, T, Seney, M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item Short-Form Health Survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther 2008; 88: 733–46.Google Scholar
Oertel, WH, Wolters, E, Sampaio, C, et al. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: the PELMOPET study. Mov Disord 2006; 21: 343–53.Google Scholar
Hauser, RA, Auinger, P, Parkinson Study Group. Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord 2011; 26: 813–8.Google Scholar
Goetz, CG, Fahn, S, Martinez-Martin, P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22: 41–7.Google Scholar
Goetz, CG, Tilley, BC, Shaftman, SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129–70.Google Scholar
Goetz, CG, Stebbins, GT, LaPelle, N, Huang, J, Tilley, BC. MDS-UPDRS non-English translation program. Mov Disord 2012; 27 (Suppl. 1): S96.Google Scholar
Poewe, W, Hauser, R, Lang, AE. Rasagiline 1 mg/day provides benefits in the progression of nonmotor symptoms in patients with early Parkinson's disease: Assessment with the revised MDS-UPDRS. Mov Disord 2009; 24 (Suppl. 1): S272.Google Scholar
Lang, AE, Eberly, S, Goetz, CG, et al. Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord 2013; 28: 1980–6.Google Scholar
Goetz, CG, Stebbins, GT, Simkus, V. Severity ranges on the MDS-UPDRS motor examination: comparison to CGI-severity scores. Mov Disord 2009; 24 (Suppl. 1): S434.Google Scholar
Stebbins, GT, Goetz, CG, Simkus, V. Minimal clinically important change and the MDS-UPDRS motor examination. Mov Disord 2009; 24 (Suppl. 1): S436.Google Scholar
Merello, M, Gerschcovich, ER, Ballesteros, D, Cerquetti, D. Correlation between the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and the Unified Parkinson's Disease Rating Scale (UPDRS) during l-dopa acute challenge. Parkinsonism Relat Disord 2011; 17: 705–7.Google Scholar
Goetz, CG, Stebbins, GT, Tilley, BC. Calibration of Unified Parkinson's Disease Rating Scale scores to Movement Disorder Society – Unified Parkinson's Disease rating scale scores. Mov Disord 2012; 27: 1239–42.Google Scholar
Verbaan, D, van Rooden, SM, Benit, CP, et al. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 632–4.CrossRefGoogle ScholarPubMed
Marinus, J, Visser, M, Stiggelbout, AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75: 388–95.CrossRefGoogle Scholar
Martínez-Martín, P, Benito-León, J, Burguera, JA, et al. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 2005; 58: 674–9.Google Scholar
Schwab, R, England, A. Third Symposium for Parkinson’s Disease. Edinburgh, UK: Livingstone; 1969; 152–7.Google Scholar
Martinez-Martin, P, Prieto, L, Forjaz, MJ. Longitudinal metric properties of disability rating scales for Parkinson's disease. Value Health 2006; 9: 386–93.Google Scholar
Schrag, A, Spottke, A, Quinn, NP, Dodel, R. Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord 2009; 24: 813–18.Google Scholar
Guy, W. Abnormal involuntary movement scale. In: ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Government Printing Office; 1976; 534–7.Google Scholar
Colosimo, C, Martínez-Martín, P, Fabbrini, G, et al. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. Mov Disord 2010; 25: 1131–42.Google Scholar
Goetz, CG, Stebbins, GT, Chung, KA, et al. Which dyskinesia scale best detects treatment response? Mov Disord 2013; 28: 341–6.Google Scholar
Goetz, CG, Stebbins, GT, Shale, HM, et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994; 9: 390–4.Google Scholar
Goetz, CG, Stebbins, GT, Chung, KA, et al. Which dyskinesia scale best detects treatment response? Mov Disord 2013; 28: 341–6.Google Scholar
Goetz, CG, Nutt, JG, Stebbins, GT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord 2008; 23: 2398–403.Google Scholar
Colosimo, C. Dyskinesia rating scales in Parkinson's disease. In: Sampaio, C, Goetz, CG, Schrag, A, eds. Rating Scales in Parkinson’s Disease. New York: Oxford University Press; 2012; 84–98.Google Scholar
Chaudhuri, KR, Martinez-Martin, P, Brown, RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007; 22: 1901–11.Google Scholar
Martinez-Martin, P, Rodriguez-Blazquez, C, Abe, K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009; 73: 1584–91.Google Scholar
Reddy, P, Martinez-Martin, P, Rizos, A, et al. Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects. Clin Neuropharmacol 2012; 35: 205–7.Google Scholar
Chaudhuri, KR, Martinez-Martin, P, Antonini, A, et al. Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. Parkinsonism Relat Disord 2013; 19: 660–5.Google Scholar
Marinus, J, Visser, M, Verwey, NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61: 1222–8.Google Scholar
Carod-Artal, FJ, Martínez-Martin, P, Kummer, W, Ribeiro, LdaS. Psychometric attributes of the SCOPA-COG Brazilian version. Mov Disord 2008; 23: 81–7.Google Scholar
Forjaz, MJ, Frades-Payo, B, Rodriguez-Blazquez, C, Ayala, A, Martinez-Martin, P. Should the SCOPA-COG be modified? A Rasch analysis perspective. Eur J Neurol 2010; 17: 202–7.Google Scholar
Reuter, I, Mehnert, S, Sammer, G, Oechsner, M, Engelhardt, M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. J Aging Res 2012; 2012: 235765.Google Scholar
Visser, M, Verbaan, D, van Rooden, SM, et al. Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC. Mov Disord 2007; 22: 2221–8.Google Scholar
Friedberg, G, Zoldan, J, Weizman, A, Melamed, E. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 1998; 21: 280–4.Google Scholar
Rodriguez-Blazquez, C, Rojo-Abuin, JM, Alvarez-Sanchez, M, et al. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism Relat Disord 2013; 19: 889–93.Google Scholar
Stacy, M, Bowron, A, Guttman, M, et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005; 20: 726–33.Google Scholar
Stacy, M, Hauser, R. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease. J Neural Transm 2007; 114: 211–17.Google Scholar
Stacy, MA, Murphy, JM, Greeley, DR, et al. The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008; 14: 205–12.Google Scholar
Martinez-Martin, P, Tolosa, E, Hernandez, B, Badia, X, ValidQUICK Study Group. Validation of the “QUICK” questionnaire – a tool for diagnosis of “wearing-off” in patients with Parkinson's disease. Mov Disord 2008; 23: 830–6.Google Scholar
Martinez-Martin, P, Hernandez, B. The Q10 questionnaire for detection of wearing-off phenomena in Parkinson's disease. Parkinsonism Relat Disord 2012; 18: 382–5.Google Scholar
Antonini, A, Martinez-Martin, P, Chaudhuri, RK, et al. Wearing-off scales in Parkinson's disease: Critique and recommendations. Mov Disord 2011; 26: 2169–75.Google Scholar
Giladi, N, Shabtai, H, Simon, ES, et al. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000; 6: 165–70.Google Scholar
Nieuwboer, A, Rochester, L, Herman, T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture. 2009; 30: 459–63.Google Scholar
Katzenschlager, R, Schrag, A, Evans, A, et al. Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure. Neurology 2007; 69: 555–63.Google Scholar
Chaudhuri, KR, Martinez-Martin, P, Schapira, AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916–23.Google Scholar
Martinez-Martin, P, Schapira, AHV, Stocchi, F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623–9.Google Scholar
Martinez-Martin, P, Chaudhuri, KR, Rojo-Abuin, JM, et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2013; 22: 37–43.Google Scholar
Chou, KL, Taylor, JL, Patil, PG. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord 2013; 19: 966–9.Google Scholar
Weintraub, D, Mamikonyan, E, Papay, K, et al. Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease – Rating Scale. Mov Disord 2012; 27: 242–7.Google Scholar
Martinez-Martin, P, Frades-Payo, B, Agüera-Ortiz, L, Ayuga-Martinez, A. A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach. J Neurol 2012; 259: 2299–308.Google Scholar
Weintraub, D, Stewart, S, Shea, JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease (QUIP). Mov Disord 2009; 24: 1461–7.Google Scholar
Chaudhuri, KR, Pal, S, DiMarco, A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629–35.Google Scholar
Marinus, J, Visser, M, van Hilten, JJ, Lammers, GJ, Stiggelbout, AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep. 2003; 26: 1049–54.Google Scholar
Trenkwalder, C, Kohnen, R, Högl, B, et al. Parkinson's disease sleep scale – validation of the revised version PDSS-2. Mov Disord 2011; 26: 644–52.Google Scholar
Högl, B, Arnulf, I, Comella, C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 2010; 25: 2704–16.Google Scholar
Zibetti, M, Rizzone, M, Merola, A, et al. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease. Acta Neurol Scand 2013; 127: e28–32.Google Scholar
Takanashi, M, Shimo, Y, Hatano, T, Oyama, G, Hattori, N. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study. Drug Res. 2013; 63: 639–43.Google Scholar
Martinez-Martin, P, Visser, M, Rodriguez-Blazquez, C, et al. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 2008; 23: 1681–8.Google Scholar
Chahine, LM, Daley, J, Horn, S, et al. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease. Parkinsonism Relat Disord 2013; 19: 859–63.Google Scholar
Perez Lloret, S, Pirán Arce, G, Rossi, M, et al. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord 2007; 22: 107–11.Google Scholar
Manor, Y, Giladi, N, Cohen, A, Fliss, DM, Cohen, JT. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Mov Disord 2007; 22: 1917–21.Google Scholar
Evatt, ML, Chaudhuri, KR, Chou, KL, et al. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation – critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord 2009; 24: 635–46.Google Scholar
Visser, M, Marinus, J, Stiggelbout, AM, van Hilten, JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004; 19: 1306–12.Google Scholar
Rodriguez-Blazquez, C, Forjaz, MJ, Frades-Payo, B, de Pedro-Cuesta, J, Martinez-Martin, P. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol 2010; 17: 194–201.Google Scholar
Forjaz, MJ, Ayala, A, Rodriguez-Blazquez, C, Frades-Payo, B, Martinez-Martin, P. Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis. Eur J Neurol 2010; 17: 273–9.Google Scholar
Brown, RG, Dittner, A, Findley, L, Wessely, SC. The Parkinson fatigue scale. Parkinsonism Relat Disord 2005; 11: 49–55.Google Scholar
Friedman, JH, Alves, G, Hagell, P, et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord 2010; 25: 805–22.Google Scholar
Rascol, O, Fitzer-Attas, CJ, Hauser, R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol 2011; 10: 415–23.Google Scholar
Martinez-Martin, P, Jeukens-Visser, M, Lyons, KE, et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord 2011; 26: 2371–80.Google Scholar
Bergner, M, Bobbitt, RA, Carter, WB, Gilson, BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805.Google Scholar
Hunt, SM, McEwen, J, McKenna, SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185–8.Google Scholar
EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208.Google Scholar
Ware, JE Jr, Sherbourne, CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.Google Scholar
Peto, V, Jenkinson, C, Fitzpatrick, R, Greenhall, R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995; 4: 241–8.Google Scholar
Jenkinson, C, Fitzpatrick, R, Peto, V, Greenhall, R, Hyman, N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353–7.Google Scholar
Martinez-Martin, P, Deuschl, G. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Mov Disord 2007; 22: 757–65.Google Scholar
Martinez-Martin, P, Kurtis, MM. Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord 2012; 5: 105–17.Google Scholar
Peto, V, Jenkinson, C, Fitzpatrick, R. Determining minimally important differences for the PDQ-39 Parkinson's Disease Questionnaire. Age Ageing 2001; 30: 299–302.Google Scholar
Fitzpatrick, R, Norquist, JM, Jenkinson, C. Distribution-based criteria for change in health-related quality of life in Parkinson's disease. J Clin Epidemiol 2004; 57: 40–4.Google Scholar
Jenkinson, C, Fitzpatrick, R, Peto, V, Greenhall, R, Hyman, N. The PDQ-8: development and validation of a short-form Parkinson's Disease Questionnaire. Psychol Health 1997; 12: 805–14.Google Scholar
De Boer, AG, Wijker, W, Speelman, JD, de Haes, JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61: 70–4.Google Scholar
Calne, S, Schulzer, M, Mak, E, et al. Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism Relat Disord 1996; 2: 55–61.Google Scholar
Marinus, J, Visser, M, Martínez-Martín, P, van Hilten, JJ, Stiggelbout, AM. A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS. J Clin Epidemiol 2003; 56: 61–7.Google Scholar
Martínez-Martin, P, Carod-Artal, FJ, da Silveira Ribeiro, L, et al. Longitudinal psychometric attributes, responsiveness, and importance of change: an approach using the SCOPA-Psychosocial questionnaire. Mov Disord 2008; 23: 1516–23.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×